Info

Going Deep with Aaron Watson

Aaron Watson is the CEO of Piper Creative. On this show, you'll hear thoughtful, focused conversations with entrepreneurs, executives, and innovators. Guests include Nathan Chan, Kevin Kelly, Bill Peduto, Morgan Housel, Noah Kagan, Tucker Max, and Barry Ritholtz. This is the biggest business podcast in Pittsburgh.
RSS Feed Subscribe in Apple Podcasts
Going Deep with Aaron Watson
2021
August
July
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
June
May
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August
July
June
May
April
March
February
January


2015
December
November
October
September
August
July


All Episodes
Archives
Now displaying: June, 2021
Jun 28, 2021

Shea Murtaugh is the founder and president of Hoffmann Murtaugh, the largest media-only agency in Pittsburgh.

 

Shea started her company in 2004 with no capital and now leads a team of 30 people. Prior to funding Hoffman Murtaugh, Shea broke into media via broadcast sales. She’s sold every major form of media over her decorated career and blends that experience into a cocktail that delivers wins for clients.

 

In this conversation, Shea and Aaron discuss how she got her start, when to hire vs train new talent, and the degree to which she has to be the “banker” of marketing.

 

Sign up for a Weekly Email that will Expand Your Mind.

 

Shea Murtaugh’s Challenge; Journal for 5 minutes each day your ideal day one year in the future.

 

Connect with Shea Murtaugh

Linkedin

Instagram

Hoffmann Murtaugh Website

 

If you liked this interview, check out episode 418 with Marco Marandiz where we discuss how to market in the modern age, what makes an authentic brand, and the future of commerce.

 

Text Me What You Think of This Episode 412-278-7680




Underwritten by Piper Creative

Piper Creative makes creating podcasts, vlogs, and videos easy. 

 

How? Click here and Learn more.

 

We work with Fortune 500s, medium-sized companies, and entrepreneurs.

 

Follow Piper as we grow

YouTube

Instagram



Subscribe on iTunes | Stitcher | Overcast | Spotify

Jun 21, 2021

Dr. Dietrich Stephan is a geneticist, entrepreneur, and CEO of NeuBase Therapeutics. Neubase is biotech startup focused on developing precision genetic medicines.

 

Dietrich previously founded or co-founded 14 biotechnology companies, was the chair of the Human Genetics department at the University of Pittsburgh, and was the CEO of LifeX Labs, a biotechnology incubator.

 

Neubase, his latest company, is developing technology spun out of Carnegie Mellon University that aims to address genetic diseases at the DNA or RNA level by combining the highly targeted approach of traditional genetic therapies with the broad organ distribution capabilities of small molecules.

 

In April 2021 Neubase went public, trading under the ticker symbol NBSE, and has raised over $100 million in less than three years.

 

In this conversation, Dietrich and Aaron discuss why Neubase went public earlier than most biotech startups, the vicious diseases they are fighting against, and the impact of the Human Genome Project on society.

 

Sign up for a Weekly Email that will Expand Your Mind.

 

Dietrich Stephan’s Challenge; 

 

Connect with Dietrich Stephan

Linkedin

Neubase Website

 

If you liked this interview, check out episode XX with Craig Markovitz where we discuss business building, university technology transfer, and life after a successful startup.



Text Me What You Think of This Episode 412-278-7680




Underwritten by Piper Creative

Piper Creative makes creating podcasts, vlogs, and videos easy. 

 

How? Click here and Learn more.

 

We work with Fortune 500s, medium-sized companies, and entrepreneurs.

 

Follow Piper as we grow

YouTube

Instagram



Subscribe on iTunes | Stitcher | Overcast | Spotify

Jun 14, 2021

Jonathan Steckbeck is the founder of Peptilogics, a biotechnology platform company that develops best-in-class novel peptide drugs for unmet medical needs. He also has a PhD in Biochemistry and Molecular Genetics from the University of Pittsburgh’s School of Medicine.

 

Amongst other problems, his company Peptilogics is focused on developing a new category of antibiotics. It has been 20 years since there was a genuinely new class of antibiotics, yet bacterial cells have continued to evolve and develop into drug-resistant infections.

 

In this interview, Jonathan and Aaron discuss the founding of Peptilogics, why they’re focused on this new modality of medication, and the FDA approval process.

 

Sign up for a Weekly Email that will Expand Your Mind.

 

Jonathan Steckbeck’s Challenge; If there’s something that you want to do that doesn’t exist, go do it.

 

Connect with Jonathan Steckbeck

Linkedin

Peptilogics Website

 

If you liked this interview, check out episode 456 with Pete DeComo where we discuss the long, arduous process of developing a medical device and episode 443 with Blake Dube where we talk about better oxygen tanks.

 

Text Me What You Think of This Episode 412-278-7680




Underwritten by Piper Creative

Piper Creative makes creating podcasts, vlogs, and videos easy. 

 

How? Click here and Learn more.

 

We work with Fortune 500s, medium-sized companies, and entrepreneurs.

 

Follow Piper as we grow

YouTube

Instagram



Subscribe on iTunes | Stitcher | Overcast | Spotify 

Jun 7, 2021

Euan Guttridge is the Director of Technical Program Management at Waymo and previously held the same position with Uber’s self-driving car division.

 

Between these two roles, Euan developed an angel investing syndicate under the banner Reinforced Ventures. The syndicate differentiates itself for the technical proficiency of its limited partners, bringing a fresh perspective to the companies it invests in.

 

Euan’s portfolio includes a number of past Going Deep podcast guests including; Gridwise, Locomation, UpContent, Fifth Season, Edge Case Research, and Honeycomb Credit. While not geographically exclusive, Reinforced does focus on Pittsburgh because of its over $10 billion of academic research funded and $6.6 billion of private funding in technology over the past decade.

 

In this conversation, Euan and Aaron discuss a career developing autonomous vehicle technology, how an AngelList syndicate works, and how to do thorough due diligence.

 

Sign up for a Weekly Email that will Expand Your Mind.

 

Euan Guttridge’s Challenge; Follow your curiosity.

 

Connect with Euan Guttridge

Linkedin

Reinforced Ventures Website

euan@reinforcedventures.com

 

If you liked this interview, check out some of Euan’s portfolio companies like Locomation’s Çetin Meriçli, Edge Case Research’s Mike Wagner, and Gridwise’s Ryan Green.

 

Text Me What You Think of This Episode 412-278-7680




Underwritten by Piper Creative

Piper Creative makes creating podcasts, vlogs, and videos easy. 

 

How? Click here and Learn more.

 

We work with Fortune 500s, medium-sized companies, and entrepreneurs.

 

Follow Piper as we grow

YouTube

Instagram



Subscribe on iTunes | Stitcher | Overcast | Spotify

1